The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

DSpace Repository

The molecular interaction pattern of lenvatinib enables inhibition of wild-type or kinase-mutated FGFR2-driven cholangiocarcinoma

Author: Spahn, Stephan; Kleinhenz, Fabian; Shevchenko, Ekaterina; Stahl, Aaron; Rasen, Yvonne; Geisler, Christine; Ruhm, Kristina; Klaumuenzer, Marion; Kronenberger, Thales; Laufer, Stefan A.; Sundberg-Malek, Holly; Bui, Khac Cuong; Horger, Marius; Biskup, Saskia; Schulze-Osthoff, Klaus; Templin, Markus; Malek, Nisar P.; Poso, Antti; Bitzer, Michael
Tübinger Autor(en):
Spahn, Stephan
Kleinhenz, Fabian
Shevchenko, Ekaterina
Stahl, Aaron
Rasen, Yvonne
Geisler, Christine
Ruhm, Kristina
Kronenberger, Thales
Bui, Khac Cuong
Schulze-Osthoff, Klaus
Poso, Antti
Bitzer, Michael
Laufer, Stefan
Sundberg Malek, Holly
Horger, Marius
Templin, Markus F.
Malek, Nisar Peter
Published in: Nature Communications (2024), Bd. 15 (1), Article 1287
Verlagsangabe: Berlin : Nature Portfolio
Language: English
Full text: http://dx.doi.org/10.1038/s41467-024-45247-6
ISSN: 2041-1723
DDC Classifikation: 500 - Natural sciences and mathematics
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)